title: cFLIP is critical for oligodendrocyte protection from inflammation.
abstract: Neuroinflammation associated with degenerative central nervous system disease and injury frequently results in oligodendrocyte death. While promoting oligodendrocyte viability is a major therapeutic goal, little is known about protective signaling strategies. We report that in highly purified rat oligodendrocytes, interferon gamma (IFNγ) activates a signaling pathway that protects these cells from tumor necrosis factor alpha (TNFα)-induced cytotoxicity. IFNγ protection requires Jak (Janus kinase) activation, components of the integrated stress response and NF-κB activation. Although NF-κB activation also occurred transiently in the absence of IFNγ and presence of TNFα, this activation was not sufficient to prevent induction of the TNFα-responsive cell death pathway. Genetic inhibition of NF-κB translocation to the nucleus abrogated IFNγ-mediated protection and did not change the cell death induced by TNFα, suggesting that NF-κB activation via IFNγ induces a different set of responses than activation of NF-κB via TNFα. A promising candidate is the NF-κB target cFLIP (cellular FLICE (FADD-like IL-1β-converting enzyme)-inhibitory protein), which is protease-deficient caspase homolog that inhibits caspase-3 activation. We show that IFNγ-mediated protection led to upregulation of cFLIP. Overexpression of cFLIP was sufficient for oligodendrocyte protection from TNFα and short hairpin RNA knockdown of cFLIP-abrogated IFNγ -mediated protection. To determine the relevance of our in vitro finding to the more complex in vivo situation, we determined the impact on oligodendrocyte death of regional cFLIP loss of function in a murine model of neuroinflammation. Our data show that downregulation of cFLIP during inflammation leads to death of oligodendrocytes and decrease of myelin in vivo. Taken together, we show that IFNγ-mediated induction of cFLIP expression provides a new mechanism by which this cytokine can protect oligodendrocytes from TNFα-induced cell death.
authors: Department of Biomedical Genetics, School of Medicine and Dentistry, University of Rochester, Rochester, NY 14642, USA.
authors: D C
authors: DC
authors: Tanner
authors: Department of Biomedical Genetics, School of Medicine and Dentistry, University of Rochester, Rochester, NY 14642, USA.
authors: A
authors: A
authors: Campbell
authors: Department of Neurobiology and Anatomy, School of Medicine and Dentistry, University of Rochester, 601 Elmwood Avenue, Box 633, Rochester, NY 14642, USA.
authors: K M
authors: KM
authors: O'Banion
authors: Department of Biomedical Genetics, School of Medicine and Dentistry, University of Rochester, Rochester, NY 14642, USA.
authors: M
authors: M
authors: Noble
authors: Department of Biomedical Genetics, School of Medicine and Dentistry, University of Rochester, Rochester, NY 14642, USA.
authors: M
authors: M
authors: Mayer-Pröschel
mesh_terms: D000818:Animals; D017209:Apoptosis / Q000187:drug effects / Q000502:physiology; D053446:CASP8 and FADD-Like Apoptosis Regulating Protein / Q000378:metabolism*; D020169:Caspases / Q000378:metabolism; D002478:Cells, Cultured; D004789:Enzyme Activation; D005260:Female; D007249:Inflammation / Q000378:metabolism* / Q000473:pathology; D007371:Interferon-gamma / Q000494:pharmacology; D053612:Janus Kinases / Q000378:metabolism; D008297:Male; D051379:Mice; D008822:Mice, Transgenic; D016328:NF-kappa B / Q000378:metabolism; D009836:Oligodendroglia / Q000187:drug effects / Q000378:metabolism* / Q000473:pathology; D051381:Rats; D015398:Signal Transduction
chemical_list: D053446:CASP8 and FADD-Like Apoptosis Regulating Protein; D016328:NF-kappa B; D007371:Interferon-gamma; D053612:Janus Kinases; D020169:Caspases
references: Brain. 2005 Nov;128(Pt 11):2675-88
references: 16219674
references: J Clin Invest. 2001 Feb;107(3):247-54
references: 11160145
references: Eur J Cancer Clin Oncol. 1986 Apr;22(4):419-26
references: 3089802
references: Dev Neurosci. 1992;14(2):93-7
references: 1382941
references: Expert Opin Ther Targets. 2003 Aug;7(4):559-73
references: 12885274
references: Annu Rev Immunol. 2000;18:621-63
references: 10837071
references: Neuron. 2002 Nov 14;36(4):585-96
references: 12441049
references: J Neurosci. 2007 Aug 29;27(35):9301-9
references: 17728444
references: Science. 1994 Jun 3;264(5164):1415-21
references: 8197455
references: Crit Rev Oncol Hematol. 2013 Mar;85(3):363-72
references: 22944363
references: J Neurooncol. 2004 Mar-Apr;67(1-2):167-76
references: 15072464
references: Am J Pathol. 2008 Nov;173(5):1508-17
references: 18818381
references: J Neurosci Res. 1999 Feb 15;55(4):514-22
references: 10723061
references: Proc Natl Acad Sci U S A. 2007 Jan 16;104(3):1027-32
references: 17209010
references: Proc Natl Acad Sci U S A. 2001 Sep 25;98(20):11450-5
references: 11553794
references: Front Mol Neurosci. 2014 May 26;7:47
references: 24904273
references: J Cell Biol. 2005 May 23;169(4):603-12
references: 15911877
references: PLoS One. 2012;7(5):e36408
references: 22574154
references: Mol Med. 1995 Nov;1(7):732-43
references: 8612196
references: Trends Neurosci. 1996 Aug;19(8):331-8
references: 8843602
references: Glia. 2010 Jan 15;58(2):195-208
references: 19606498
references: Eur J Neurosci. 1996 Jun;8(6):1106-16
references: 8752580
references: Neurology. 1987 Jul;37(7):1097-102
references: 3110648
references: EMBO J. 1997 Jan 15;16(2):406-16
references: 9029159
references: Proc Natl Acad Sci U S A. 1994 Jul 5;91(14):6288-92
references: 7912826
references: J Clin Invest. 2007 Feb;117(2):297-9
references: 17273549
references: Int J Clin Exp Med. 2013;6(1):16-25
references: 23236554
references: J Immunol. 1996 Jan 1;156(1):5-7
references: 8598493
references: Nat Protoc. 2009;4(4):495-505
references: 19300443
references: J Neurosci Res. 2004 Jun 15;76(6):846-61
references: 15160396
references: Mol Cell Neurosci. 1998 Dec;12(6):376-89
references: 9888990
references: Mol Cell Neurosci. 2000 Oct;16(4):338-49
references: 11085872
references: Nat Rev Drug Discov. 2007 Dec;6(12):975-90
references: 18049472
references: Nat Rev Neurosci. 2004 Dec;5(12):931-42
references: 15550948
references: Nat Immunol. 2004 Feb;5(2):199-207
references: 14730360
references: J Immunol. 1996 Oct 15;157(8):3223-7
references: 8871615
references: Mol Cell Neurosci. 1997;9(5-6):420-32
references: 9361279
references: Dev Biol. 1993 Oct;159(2):618-30
references: 8405684
references: J Neuroinflammation. 2008;5:7
references: 18302763
references: Proc Natl Acad Sci U S A. 2002 Dec 10;99(25):16220-5
references: 12451177
references: J Immunol. 2001 Aug 1;167(3):1821-9
references: 11466408
references: J Neurosci Res. 2009 Nov 15;87(15):3241-9
references: 19330777
references: J Interferon Cytokine Res. 2005 Nov;25(11):707-19
references: 16318585
references: Proc Natl Acad Sci U S A. 1994 Aug 2;91(16):7496-500
references: 7914368
references: Trends Neurosci. 1997 Jun;20(6):252-8
references: 9185306
references: J Neurosci Res. 1998 Apr 15;52(2):230-9
references: 9579413
references: J Neurosci. 2011 Apr 20;31(16):6235-46
references: 21508246
references: Am J Pathol. 1998 Sep;153(3):801-13
references: 9736029
references: J Clin Invest. 2007 Jun;117(6):1595-604
references: 17549256
references: Annu Rev Biochem. 1998;67:227-64
references: 9759489
references: Glia. 2005 Nov 1;52(2):127-43
references: 15920731
references: J Neurosci Res. 1998 Dec 1;54(5):574-83
references: 9843148
references: J Neuropathol Exp Neurol. 2000 Apr;59(4):280-6
references: 10759183
references: Microbiol Mol Biol Rev. 2006 Dec;70(4):1032-60
references: 17158706
references: J Neurosci. 2007 Feb 21;27(8):2013-24
references: 17314297
references: Nat Neurosci. 2009 Apr;12(4):379-85
references: 19287390
references: EMBO J. 1997 Jan 15;16(2):306-17
references: 9029151
references: J Neurosci. 2013 Apr 3;33(14):5980-91
references: 23554479
references: J Immunol. 2001 May 15;166(10):6170-80
references: 11342638
references: J Immunol. 2003 Nov 15;171(10):5313-9
references: 14607933
references: Proc Natl Acad Sci U S A. 1979 Jan;76(1):514-7
references: 284369
references: J Neuroimmunol. 1995 Feb;56(2):135-41
references: 7860709
references: J Clin Invest. 2007 Feb;117(2):448-56
references: 17273557
references: J Immunol. 2006 Mar 1;176(5):3173-80
references: 16493077
references: Nat Rev Immunol. 2006 Mar;6(3):196-204
references: 16498450